论文部分内容阅读
河南医科大学癌前期研究与河南省卫生厅、 省医科院等的科科研人员协作,在鹤壁市进行了为期12年的食管癌癌前病变预防性试验(即现场一级预防),让食管上皮癌前增生患者补充复合核黄素(黄豆渣发酵制品,含多种维生素、微量元素和氨基酸),结果总体癌变抑制率达57％,总体好转增加率达20.6％。
The precancer research of Henan Medical University cooperated with scientific researchers of the Henan Provincial Department of Health and the Provincial Academy of Medical Sciences to conduct a 12-year prophylactic test for precancerous lesions of esophageal cancer (ie, on-site primary prevention) in Hebi City to allow esophageal epithelium. Patients with precancerous hyperplasia supplemented with compound riboflavin (soybean residue fermentation products, containing multiple vitamins, trace elements, and amino acids), the overall cancer inhibition rate was 57%, and the overall improvement rate was 20.6%.